CsgD protein levels are downregulated in the STM1344 mutant .
Upon the deletion of STM1344 in STM1827 mutant backgrounds , the downregulation of CsgD expression to the level in the UMR1 wild type was observed , while in STM3611 mutant backgrounds , CsgD expression remained at the levels in the corresponding single mutants .
Upon the deletion of STM1344 in STM1827 mutant backgrounds , the downregulation of CsgD expression to the level in the UMR1 wild type was observed , while in the STM1703 , CsgD expression remained at the levels in the corresponding single mutants .
Upon the deletion of STM1344 in STM1827 mutant backgrounds , the downregulation of rdar morphotype to the level in the UMR1 wild type was observed , while in STM3611 mutant backgrounds , CsgD expression remained at the levels in the corresponding single mutants .
Upon the deletion of STM1344 in STM1827 mutant backgrounds , the downregulation of rdar morphotype to the level in the UMR1 wild type was observed , while in the STM1703 , CsgD expression remained at the levels in the corresponding single mutants .
Upon the deletion of STM1344 in the STM4264 , the downregulation of CsgD expression to the level in the UMR1 wild type was observed , while in STM3611 mutant backgrounds , CsgD expression remained at the levels in the corresponding single mutants .
Upon the deletion of STM1344 in the STM4264 , the downregulation of CsgD expression to the level in the UMR1 wild type was observed , while in the STM1703 , CsgD expression remained at the levels in the corresponding single mutants .
Upon the deletion of STM1344 in the STM4264 , the downregulation of rdar morphotype to the level in the UMR1 wild type was observed , while in STM3611 mutant backgrounds , CsgD expression remained at the levels in the corresponding single mutants .
Upon the deletion of STM1344 in the STM4264 , the downregulation of rdar morphotype to the level in the UMR1 wild type was observed , while in the STM1703 , CsgD expression remained at the levels in the corresponding single mutants .
STM1344 favors sessility by repressing the expression of the two phosphodiesterases , STM3611 , required for the downregulation of CsgD expression .
STM1344 favors sessility by repressing the expression of the two phosphodiesterases , STM1703 , required for the downregulation of CsgD expression .
Protein Domain class Enzymatic Phenotypes affected by a deletion mutation ‡ Comments † GGDEF EAL activity STM1344 -- III no PDE activity , Downregulation of motility , upregulation of rdar morphotype Complements a STM1697 no c-di-GMP Stimulation of CsgD expression mutant .